Centre approves Bharat Biotech’s nasal Covid vaccine for booster dose; To be available on CoWIN app from today

The Government today granted approval to Bharat Biotech’s nasal Covid vaccine for booster dose. According to sources in the Health Ministry, the nasal vaccine has been approved for those aged above 18 years. It said the vaccine will be available in private hospitals for a booster dose in the initial phase and will be introduced on the Co-WIN platform today.

The nasal vaccine BBV154 had received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.

The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries around the world.